Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,166 | 643 | 99.4% |
| Gift | $59.40 | 1 | 0.4% |
| Education | $31.60 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,044 | 68 | $0 (2024) |
| Insulet Corporation | $1,853 | 97 | $0 (2024) |
| Lilly USA, LLC | $1,821 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,071 | 29 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,052 | 45 | $0 (2024) |
| Abbott Laboratories | $632.22 | 30 | $0 (2024) |
| Amgen Inc. | $630.86 | 22 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $551.02 | 19 | $0 (2024) |
| Radius Health, Inc. | $503.48 | 19 | $0 (2024) |
| Dexcom, Inc. | $496.26 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,721 | 164 | Insulet Corporation ($672.42) |
| 2023 | $3,729 | 148 | Lilly USA, LLC ($542.86) |
| 2022 | $3,225 | 147 | Novo Nordisk Inc ($455.88) |
| 2021 | $2,749 | 100 | Novo Nordisk Inc ($518.64) |
| 2020 | $1,055 | 42 | AstraZeneca Pharmaceuticals LP ($188.23) |
| 2019 | $1,587 | 43 | Novo Nordisk Inc ($305.32) |
| 2018 | $142.08 | 2 | Dexcom, Inc. ($124.99) |
| 2017 | $48.34 | 1 | Novo Nordisk Inc ($48.34) |
All Payment Transactions
647 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes Care | ||||||
| 12/20/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.38 | General |
| Category: Insulin Pump | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.88 | General |
| Category: Insulin Pump | ||||||
| 12/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: Insulin Pump | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.13 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/06/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.64 | General |
| Category: Insulin Pump | ||||||
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.13 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $25.71 | General |
| Category: Insulin Pump | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.49 | General |
| Category: Insulin Pump | ||||||
| 11/18/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.51 | General |
| 11/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $4.75 | General |
| Category: Insulin Pump | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Automated insulin delivery system | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $4.84 | General |
| Category: Insulin Pump | ||||||
| 11/06/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 10/30/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.08 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 162 | 261 | $68,986 | $22,106 |
| 2022 | 7 | 379 | 512 | $150,105 | $48,033 |
| 2021 | 6 | 431 | 540 | $112,390 | $54,410 |
| 2020 | 6 | 412 | 610 | $101,347 | $37,822 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 128 | $38,400 | $12,415 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $10,000 | $3,156 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 24 | $8,400 | $2,989 | 35.6% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 14 | 28 | $3,646 | $1,301 | 35.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 22 | 39 | $4,290 | $1,129 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 17 | $4,250 | $1,117 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 271 | $81,300 | $26,178 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $28,000 | $8,170 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 34 | $11,900 | $4,994 | 42.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 33 | 46 | $9,725 | $3,047 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $9,000 | $2,708 | 30.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 36 | 53 | $5,680 | $1,531 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $4,500 | $1,405 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 269 | $60,399 | $29,597 | 49.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 107 | 107 | $29,850 | $15,040 | 50.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $6,750 | $3,157 | 46.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 45 | $6,423 | $2,929 | 45.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 46 | 68 | $4,288 | $1,977 | 46.1% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 18 | 18 | $4,680 | $1,709 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 263 | $56,817 | $20,526 | 36.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 70 | 70 | $22,109 | $8,156 | 36.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 55 | 55 | $11,355 | $4,777 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 52 | $7,468 | $2,795 | 37.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 21 | 36 | $2,518 | $1,046 | 41.5% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 83 | 134 | $1,080 | $523.02 | 48.4% |
About Dr. Andreina Rojas, M.D
Dr. Andreina Rojas, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in South Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1245542208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreina Rojas, M.D has received a total of $16,257 in payments from pharmaceutical and medical device companies, with $3,721 received in 2024. These payments were reported across 647 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($16,166).
As a Medicare-enrolled provider, Rojas has provided services to 1,384 Medicare beneficiaries, totaling 1,923 services with total Medicare billing of $162,371. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location South Miami, FL
- Active Since 07/07/2010
- Last Updated 11/21/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245542208
Products in Payments
- Omnipod (Device) $1,853
- JARDIANCE (Drug) $1,330
- FARXIGA (Drug) $964.33
- Ozempic (Drug) $830.86
- Wegovy (Drug) $553.83
- t:slim X2 Insulin Pump with Control-IQ (Device) $518.87
- UNITHROID (Drug) $488.48
- SOLIQUA 100/33 (Biological) $477.40
- AFREZZA (Drug) $429.07
- Kerendia (Drug) $426.06
- FREESTYLE LIBRE 2 (Device) $412.91
- Rybelsus (Drug) $352.06
- Korlym (Drug) $337.39
- TOUJEO (Biological) $309.25
- CeQur Simplicity (Device) $295.29
- Vascepa (Drug) $287.97
- Senza (Device) $281.69
- MOUNJARO (Drug) $269.69
- EVENITY (Biological) $256.87
- Dexcom G6 Transmitter (Medical Supply) $246.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in South Miami
Dr. Lara Paraskos, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $51,328
Julio Pita, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $18,761
Bianca Alfonso, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $16,477
Daisy Acevedo Morales, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,873
Dr. Diane Krieger, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,223
Nora Khoury
Endocrinology, Diabetes & Metabolism — Payments: $2,082